Engineered T cells hold immense potential for immunotherapy, and there are many ways to amend or create immunotherapies using gene editing.

New methods of characterizing gene-edited cells need to be implemented to accelerate therapeutic efficacy and outcomes, such as potency and reducing immune-related adverse events.

Download this eBook to learn how our Functional Proteomics is changing genome editing & engineering for cell immunotherapy.